According to Nevro 's latest financial reports the company's current revenue (TTM) is $0.42 B. In 2022 the company made a revenue of $0.40 B an increase over the years 2021 revenue that were of $0.38 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.42 B | 4.63% |
2022 | $0.40 B | 5.03% |
2021 | $0.38 B | 6.87% |
2020 | $0.36 B | -7.23% |
2019 | $0.39 B | 0.77% |
2018 | $0.38 B | 18.56% |
2017 | $0.32 B | 42.96% |
2016 | $0.22 B | 228.28% |
2015 | $69.6 M | 113.69% |
2014 | $32.57 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $42.85 B | 9,979.87% | ๐บ๐ธ USA |
Abiomed ABMD | $1.07 B | 152.63% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | $7.12 B | 1,575.57% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | $0.74 B | 75.61% | ๐บ๐ธ USA |